The TransAlgae platform enables the introduction of protein drugs, such as vaccines, immune- modulators etc. into algae and to deliver them orally to the target animal, through feed, replacing the need for injections. Cost-effective, Efficient, Fast and Safe
| Website | http://www.transalgae.com |
| Revenue | $6 million |
| Employees | 18 (6 on RocketReach) |
| Founded | 2008 |
| Address | 2 Pekeris St. Weizmann Science Park Rehovot, Rehovot, Central District 7670202, IL |
| Phone | +972 8-936-6167 |
| Industry | Biotechnology, Animals & Livestock, Agriculture |
| Keywords | Novel Drug Delivery Systems, Next Generation Vaccines, Plant Based Pharmaceuticals, Algae Biotechnology, Biotechnological Advancements, Animal Health Solutions, Innovative Drug Delivery |
| Competitors | BASF, Green Plains Inc., Renewable Energy Group, Inc., Cyanotech Corporation, AlgaEnergy, Solabia-Algatech Nutrition, Algenol, Verdezyne, AlgiSys, LLC - an ESG Company, Cellana Inc. +21 more (view full list) |
| SIC | SIC Code 0919 Companies, SIC Code 09 Companies, SIC Code 091 Companies |
| NAICS | NAICS Code 112 Companies, NAICS Code 11 Companies |
Looking for a particular TransAlgae employee's phone or email?
The TransAlgae annual revenue was $6 million in 2026.
Maor Sasson is the CEO of TransAlgae.
6 people are employed at TransAlgae.
TransAlgae is based in Rehovot, Central District.
The NAICS codes for TransAlgae are [112, 11].
The SIC codes for TransAlgae are [919, 9, 91].